Compare ETSY & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETSY | TFX |
|---|---|---|
| Founded | 2005 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.3B |
| IPO Year | 2015 | 1994 |
| Metric | ETSY | TFX |
|---|---|---|
| Price | $57.72 | $130.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 26 | 8 |
| Target Price | $62.50 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 3.1M | 948.9K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | $441,231,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $3.44 | $5.15 |
| P/E Ratio | $96.02 | ★ N/A |
| Revenue Growth | ★ 20.90 | N/A |
| 52 Week Low | $44.00 | $100.18 |
| 52 Week High | $76.52 | $139.67 |
| Indicator | ETSY | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 55.46 |
| Support Level | $55.62 | $117.57 |
| Resistance Level | $64.74 | $134.47 |
| Average True Range (ATR) | 2.70 | 4.51 |
| MACD | -1.17 | -0.42 |
| Stochastic Oscillator | 9.80 | 60.81 |
Founded in 2005, Etsy operates a leading global marketplace, connecting roughly 87 million active buyers and 6 million sellers of unique, handmade, and vintage goods. In fiscal 2025, the firm generated $2.9 billion in revenue and almost $12 billion in gross merchandise sales. The firm monetizes its marketplace primarily through transaction fees and advertising, with core categories spanning homeware, jewelry, apparel, and craft supplies. The US drives 74% of sales, though its core geographic reach extends to the UK, Germany, Canada, and Australia.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.